139 related articles for article (PubMed ID: 3883743)
1. Optimum effectiveness of intestinal alpha-glucosidase inhibitors: importance of uniform distribution through a meal.
O'Dea K; Turton J
Am J Clin Nutr; 1985 Mar; 41(3):511-6. PubMed ID: 3883743
[TBL] [Abstract][Full Text] [Related]
2. Scope and specificity of acarbose in slowing carbohydrate absorption in man.
Jenkins DJ; Taylor RH; Goff DV; Fielden H; Misiewicz JJ; Sarson DL; Bloom SR; Alberti KG
Diabetes; 1981 Nov; 30(11):951-4. PubMed ID: 7028548
[TBL] [Abstract][Full Text] [Related]
3. Acute and short term effects of intestinal alpha-glucosidase inhibition on gut hormone responses in man.
Uttenthal LO; Ukponmwan OO; Ghiglione M; Bloom SR
Dig Dis Sci; 1987 Feb; 32(2):139-44. PubMed ID: 3542445
[TBL] [Abstract][Full Text] [Related]
4. The effects of an alpha-glucoside hydrolase inhibitor on glycemia and the absorption of sucrose in man determined using a tracer method.
Radziuk J; Kemmer F; Morishima T; Berchtold P; Vranic M
Diabetes; 1984 Mar; 33(3):207-13. PubMed ID: 6365657
[TBL] [Abstract][Full Text] [Related]
5. Combined use of guar and acarbose in reduction of postprandial glycaemia.
Jenkins DJ; Taylor RH; Nineham R; Goff DV; Bloom SR; Sarson D; Alberti KG
Lancet; 1979 Nov; 2(8149):924-7. PubMed ID: 91023
[TBL] [Abstract][Full Text] [Related]
6. alpha-Glucosidase inhibition improves postprandial hyperglycemia and decreases insulin requirements in insulin-dependent diabetes mellitus.
Dimitriadis GD; Tessari P; Go VL; Gerich JE
Metabolism; 1985 Mar; 34(3):261-5. PubMed ID: 3883097
[TBL] [Abstract][Full Text] [Related]
7. Response of serum levels of gastric inhibitory polypeptide and insulin to sucrose ingestion during long-term application of acarbose.
Fölsch UR; Ebert R; Creutzfeldt W
Scand J Gastroenterol; 1981; 16(5):629-32. PubMed ID: 7034156
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of disaccharide digestion in rat intestine by the alpha-glucosidase inhibitor acarbose (BAY g 5421).
Krause HP; Keup U; Puls W
Digestion; 1982; 23(4):232-8. PubMed ID: 6754513
[TBL] [Abstract][Full Text] [Related]
9. Manipulation of gut hormone response to food by soluble fiber and alpha-glucosidase inhibition.
Jenkins DJ; Taylor RH; Nineham R; Goff DV; Bloom SR; Sarson DL; Misiewicz JJ; Alberti KG
Am J Gastroenterol; 1988 Apr; 83(4):393-7. PubMed ID: 2831707
[TBL] [Abstract][Full Text] [Related]
10. Fate and effects of the alpha-glucosidase inhibitor acarbose in humans. An intestinal slow-marker perfusion study.
Ruppin H; Hagel J; Feuerbach W; Schutt H; Pichl J; Hillebrand I; Bloom S; Domschke W
Gastroenterology; 1988 Jul; 95(1):93-9. PubMed ID: 3286363
[TBL] [Abstract][Full Text] [Related]
11. The effects of the alpha-glucosidase inhibitor BAY g 5421 (Acarbose) on postprandial blood glucose, serum insulin, and triglyceride levels: dose-time-response relationships in man.
Hillebrand I; Boehme K; Frank G; Fink H; Berchtold P
Res Exp Med (Berl); 1979 Apr; 175(1):87-94. PubMed ID: 375343
[TBL] [Abstract][Full Text] [Related]
12. Effects of the disaccharidase inhibitor acarbose on meal and intravenous glucose tolerance in normal man.
Dimitriadis G; Tessari P; Go V; Gerich J
Metabolism; 1982 Aug; 31(8):841-3. PubMed ID: 7047984
[TBL] [Abstract][Full Text] [Related]
13. The effects of the alpha-glucosidase inhibitor BAY g 5421 (Acarbose) on meal-stimulated elevations of circulating glucose, insulin, and triglyceride levels in man.
Hillebrand I; Boehme K; Frank G; Fink H; Berchtold P
Res Exp Med (Berl); 1979 Apr; 175(1):81-6. PubMed ID: 375342
[TBL] [Abstract][Full Text] [Related]
14. Effects of acarbose on starch hydrolysis. Study in healthy subjects, ileostomy patients, and in vitro.
Hiele M; Ghoos Y; Rutgeerts P; Vantrappen G
Dig Dis Sci; 1992 Jul; 37(7):1057-64. PubMed ID: 1618053
[TBL] [Abstract][Full Text] [Related]
15. Adaptation of the small intestine to induced maldigestion in rats. Experimental pancreatic atrophy and acarbose feeding.
Creutzfeldt W; Fölsch UR; Elsenhans B; Ballmann M; Conlon JM
Scand J Gastroenterol Suppl; 1985; 112():45-53. PubMed ID: 3892654
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release.
Enç FY; Imeryüz N; Akin L; Turoğlu T; Dede F; Haklar G; Tekeşin N; Bekiroğlu N; Yeğen BC; Rehfeld JF; Holst JJ; Ulusoy NB
Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G752-63. PubMed ID: 11518688
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of sucrose- and starch-induced glycaemic and hormonal responses by the alpha-glucosidase inhibitor emiglitate (BAY o 1248) in healthy volunteers.
Lembcke B; Fölsch UR; Gatzemeier W; Lücke B; Ebert R; Siegel E; Creutzfeldt W
Eur J Clin Pharmacol; 1991; 41(6):561-7. PubMed ID: 1815967
[TBL] [Abstract][Full Text] [Related]
18. A risk-benefit appraisal of acarbose in the management of non-insulin-dependent diabetes mellitus.
Santeusanio F; Compagnucci P
Drug Saf; 1994 Dec; 11(6):432-44. PubMed ID: 7727053
[TBL] [Abstract][Full Text] [Related]
19. Effect of physical form of carbohydrate on the postprandial glucose, insulin, and gastric inhibitory polypeptide responses in type 2 diabetes.
Collier G; O'Dea K
Am J Clin Nutr; 1982 Jul; 36(1):10-4. PubMed ID: 7046411
[TBL] [Abstract][Full Text] [Related]
20. Improvement of metabolic control in insulin dependent diabetics treated with the alpha-glucosidase inhibitor acarbose for two months.
Gérard J; Luyckx AS; Lefebvre PJ
Diabetologia; 1981 Nov; 21(5):446-51. PubMed ID: 7028558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
